Da Vinci Surgical Robot System: The Future of Minimally Invasive Surgery

1. Introduction: Paradigm Shift in Modern Surgery

The history of clinical medicine has witnessed many groundbreaking revolutions, from the discovery of anesthetics that desensitize patients, antibiotics that control infections, to the advent of laparoscopic surgery that completely changed the concept of surgical trauma. Today, the surgical specialty globally is entering a profound third paradigm shift: the popularization and standardization of Robotic-Assisted Surgery (RAS).

1 Over the past three decades, the barriers of physiological and mechanical limits of the human hand have gradually been broken by sophisticated mechatronic systems, providing unimaginable precision, flexibility, and control in the narrowest surgical environments of the human body.4

The undisputed leader in this technological era is the Da Vinci surgical robot system, researched and developed by Intuitive Surgical. Since the first generation was officially approved by the U.S. Food and Drug Administration (FDA) in 2000, the Da Vinci platform has not only set the gold standard for minimally invasive surgery but also reshaped the entire healthcare ecosystem on a global scale.7 The influence of this system extends far beyond the framework of a mere medical tool; it restructures operating room infrastructure, changes the philosophy of surgical training, and poses new challenges regarding healthcare financial models as well as equity in accessing high-tech healthcare services.5

This research report is compiled to provide a comprehensive, outstanding, and multidimensional analysis of the Da Vinci surgical robot system. The analytical lenses cover from the core technical platform, historical progress, clinical efficacy demonstrated through large-scale meta-analyses, healthcare economic context, the rise of market competitors, to the overall picture of the application, training, and localization of this advanced technology in the Vietnamese market. By synthesizing a massive amount of data from clinical trials, financial reports, and technology trends, this document aims to outline a strategic vision for the future of minimally invasive surgery in the digital era.

2. The Predecessor Era and Historical Progress of the Da Vinci Platform

The concept of applying robots in medicine did not suddenly appear like a miracle but is the result of a long technological evolution, stemming from urgent needs to overcome human limitations. The first tentative step occurred in 1985 when an industrial robotic arm named PUMA 200 was adjusted and reprogrammed to stabilize a catheter in a brain tumor biopsy under the guidance of computed tomography (CT) imaging.2 Before the PUMA era, neurosurgeons had to manually calculate spatial angles and needle depth, which was exhausting and prone to errors; the intervention of automation technology opened up the possibility of instant calculations and maintaining absolute stability.2 These initial successes laid the groundwork for subsequent prototypes such as the "Probot" system introduced in 1988 for transurethral prostate resection, and the "Robodoc" system in 1992 specializing in femur milling in hip replacement surgery with precision far exceeding manual bone chiseling skills.2

However, the inherent limitations of these early systems were that they primarily operated based on pre-programmed scenarios and coordinates with narrow margins, lacking the ability to flexibly adapt to real-time physiological changes of soft tissues. The real breakthrough that shaped the foundational philosophy of Da Vinci later was the effort to research and create "Master-Slave" robot structures, where the mechanical arm does not act automatically but serves as an extension, directly simulating and refining the surgeon's hand movements. This ideology was initially driven by the U.S. military and NASA with the goal of performing remote surgery for soldiers on the battlefield or astronauts in space.

The pinnacle of this effort was recorded on September 7, 2001, through a historical milestone named "Lindbergh Operation." Inspired by legendary pilot Charles Lindbergh, the first to make a nonstop solo flight across the Atlantic, Professor Jacques Marescaux and his team from the French Institute for Digestive Cancer Research (IRCAD) performed a completely remote cholecystectomy on a 68-year-old female patient lying at the Civil Hospital of Strasbourg in Eastern France, while he himself sat at a console in New York (USA).1 By using the ZEUS robot system designed by Computer Motion and utilizing high-speed fiber optic transmission provided by France Telecom to eliminate signal delay, the 45-minute surgery (or 54 minutes according to some data recording the preparation process) was a resounding success without any complications.1 This event eloquently demonstrated that geographical barriers can be completely erased by telecommunications and mechatronic technology.1

In parallel with the development of ZEUS, Intuitive Surgical continuously refined its platform named Da Vinci. After acquiring patents and competitors, Intuitive quickly dominated the market. The first generation of Da Vinci (called the Standard system) was introduced in 1999 and officially approved by the FDA in 2000.9 This initial configuration included three robotic arms (one holding an endoscopic camera and two holding surgical instruments), providing the surgeon with an intuitive interface with groundbreaking intervention capabilities.9 By 2002, recognizing the need to improve surgical field exposure and reduce reliance on assistants standing by the table, the four-arm robotic system was approved, setting a new standard for complex interventions.9

The evolutionary process of the Da Vinci system went through groundbreaking generations, continuously expanding the limits of medicine:

• Si and X Generations: These versions established the standard foundation for multiport surgery, significantly improving ergonomics and expanding access to high-definition 3D imaging, laying a solid foundation for application in various specialties.13
• Xi Generation (launched in 2014): Dubbed by experts as the pinnacle of multiport surgical platforms, the Xi system offers superior architectural flexibility. The robotic arms are redesigned to hang on a mobile boom, allowing the camera to be mounted on any arm and changing the multi-directional surgical angle without moving the entire cart system. This allows surgeons to smoothly operate in deep, narrow anatomical regions and extend across multiple body cavities.4
• Da Vinci SP System (Single Port - 2018): Marks a strategic design branching, SP is specially crafted to bring all flexible instruments and a 3D camera through a single incision (about 2.5 cm) or intervene through the body's natural orifices. It particularly shows outstanding effectiveness in urological surgeries, tonsillectomy, and pelvic cancer treatment where the operating space is extremely limited.9
• Da Vinci 5 System (launched in 2024): As the most advanced and integrated multiport platform currently, Da Vinci 5 carries over 150 design improvements and computing power 10,000 times greater than the predecessor Xi generation. This platform not only upgrades mechanical structures but also redefines human-machine interaction through the extensive integration of new-generation sensors, especially the groundbreaking Force Feedback technology.13

3. Core Technical Structure and Breakthroughs in Mechatronics

3.1. Core Manipulation System: Console, Patient Cart, and Vision Cart

Contrary to popular misconceptions that "robots automatically perform surgeries," the Da Vinci system is essentially a passive support tool, absolutely following human guidance and control.7 The entire system is a sophisticated closed network. The standard structure of a multiport Da Vinci platform includes three separate but real-time signal-synchronized core components:

1. Surgeon Console: This is the command center of the system. The surgeon sits in the most ergonomically optimal position, freeing the body from the spinal tension commonly encountered in open surgery. The surgeon looks through a stereoscopic viewer providing high-definition 3D images, offering a panoramic, deep, and superior magnified view of microanatomical structures. From here, the surgeon uses master controls to transmit movement commands.7
2. Patient Cart: Sterilely positioned next to the operating table, this component is the mechanical embodiment of the system, containing three to four robotic arms that interact directly. These arms hold an endoscopic lens (camera) and specific microsurgical instruments. A powerful computer system receives all movements from the console, instantly filtering out all natural hand tremors (tremor reduction) and scaling down motion (motion scaling) before converting it into the robot's mechanical action, providing absolute smoothness.7
3. Vision Cart: Acting as the "central nervous system," this station connects the components. It processes the image data stream from the revolutionary 3-channel camera system, maintains ultra-low latency signal communication between the console and robotic arms, and houses energy delivery devices for cutting and coagulation.7

3.2. EndoWrist Technology: Optimizing Kinematics and Eliminating Fulcrum Effect

One of the biggest and most frustrating limitations of traditional laparoscopy is the use of straight, rigid instruments. These instruments are severely limited to 4 basic degrees of freedom and are subject to the "fulcrum effect" syndrome at the point of entry through the abdominal wall. Due to this lever effect, when the surgeon wants to move the instrument tip inside the body to the right, they must pull the handle outside to the left, and vice versa. This visual-motor inversion requires a prolonged brain training process and reduces the intuitiveness of surgery.22

The Da Vinci platform thoroughly resolves this mechanical issue with its proprietary instrument technology named EndoWrist. The micro-mechanical wrist joints of EndoWrist provide 7 degrees of freedom and the ability to bend up to 90 degrees, perfectly simulating the flexible movements of the human wrist but with a superior 360-degree rotation range.4 This capability is extremely important in techniques requiring complex suturing in ultra-narrow spaces, such as suturing the urethra to the bladder neck after total prostatectomy, or dissecting endometrial tissue bands tightly adhered to the rectum and ureters.4

3.3. Force Feedback Technology on Da Vinci 5: A Leap in Tactile Sensation

Throughout more than two decades of prosperous development, the critical and frequently criticized drawback of robotic surgery compared to traditional open surgery is the complete absence of haptic feedback or force sensation. Surgeons operating on previous generations of Da Vinci robots could only assess tissue tension based on visual signals (such as observing deformation, tissue blanching on the screen), leading to potential risks of suture breakage, tissue tearing, or damage to fragile blood vessels due to excessive force.17 The lack of "hand feel" has always been a psychological barrier for experienced open surgeons.25

The launch of Da Vinci 5 in early 2024 solved this historical problem with revolutionary Force Feedback technology. Instead of using simple vibration mechanisms to simulate artificial tactile sensation like some competing systems, Intuitive engineers integrated ultra-small force sensors directly into the proximal tips of surgical instruments – the point of direct contact with the patient's body.17 This advanced technology accurately measures every physical push and pull force exerted on soft tissue structures in real-time and transmits that mechanical signal back to the master controls at the Surgeon Console.17

The results obtained from preclinical trials are extremely impressive: activating Force Feedback helps reduce up to 43% of excessive force exerted on tissues during retraction and dissection.17 This reduction in mechanical force not only leads to the concept of "gentler surgery," significantly minimizing microscopic damage to surrounding healthy tissue, but also completely changes the dynamics of the learning curve.17 For surgeons new to the robotic world, being able to "feel" soft tissue helps them quickly grasp the principle of "gentle handling," which is the ultimate foundation of minimally invasive surgery, thereby significantly shortening the time to achieve proficiency.18 The addition of tactile sensation, perfectly synchronized with maximum 3D imaging, brings the surgical experience to the highest level of realistic simulation in medical history.17

4. Artificial Intelligence Ecosystem and Modern Clinical Data Analysis

The future of surgery does not merely lie in mechanical improvements but is strongly shifting towards the era of data and computing power. Intuitive Surgical is undergoing a strategic transformation, from a mere medical hardware manufacturer to a company building a digital healthcare ecosystem, extensively applying Artificial Intelligence (AI) and Machine Learning to analyze millions of surgeries performed worldwide.26 The groundbreaking digital components include:

• My Intuitive, Case Insights, and Performance Evaluation: Leveraging massive data from surgical videos and kinematic data collected directly from the joints of robotic arms, the AI Case Insights platform provides objective, detailed assessments of surgeon performance. Instead of relying on subjective evaluation and the subjective experience of instructors, the system accurately quantifies wasted manipulation time, the economy of each movement, the smoothness of hand trajectory, thereby offering suggestions to design personalized training pathways to optimize skills.28
• SureForm Staplers (Intelligent Stapling System): In gastric or colorectal surgery, the integrity of the anastomosis is a vital factor. Da Vinci's SureForm endoscopic stapler is equipped with a smart microprocessor capable of monitoring tissue compression thousands of times per second. The algorithm automatically analyzes tissue thickness and density, continuously adjusting compression before firing the staple, ensuring the anastomosis of blood vessels or the gastrointestinal tract achieves biomechanical perfection, minimizing the dangerous complication of anastomotic leakage.26
• Ion Endoluminal System: This is a new-generation robotic bronchoscopy platform specifically designed to access and biopsy nodules in the most remote peripheral locations of the lung, where traditional flexible bronchoscopes are completely powerless. Ion integrates AI technology combined with shape-sensing sensors. Notably, the machine's AI algorithm can compare real-time endoscopic images with a 3D model constructed from the patient's initial CT scan. As breathing deforms the lung, the system automatically adjusts the path just like a smart GPS system automatically updates the route when traffic conditions change, helping doctors accurately biopsy suspected early-stage lung cancer lesions.30
• SimNow & Telepresence: The SimNow 2 virtual reality platform allows surgeons to practice complex suturing skills right on the Surgeon Console without operating on actual patients, helping to train muscle reflexes. Furthermore, the Telepresence feature integrated through the My Intuitive cloud system allows leading experts worldwide to observe, interact, and directly advise remotely (mentoring) for complex surgeries taking place in any region, narrowing the global medical gap.26

5. Evaluation of Medical Efficacy and Clinical Application Scope

The perfect combination of maximum 3D vision (magnified many times) and flexible 7-degree-of-freedom instruments allows Da Vinci to deeply penetrate and solve anatomical challenges in most of the most complex surgical specialties.

5.1. Urology and Gynecology: Absolute Dominance

Radical Prostatectomy for cancer treatment was once a terrifying nightmare for both doctors and patients. With traditional open surgery, the rate of patients experiencing severe complications that impair quality of life, such as urinary incontinence and erectile dysfunction, is very high, due to unavoidable damage to the ultra-small nerve plexuses and dense vascular networks in the deep pelvic region. With the advent of Da Vinci, sharp observation of these microstructures and nerve-sparing became feasible and yielded excellent recovery results.15 Even for new-generation systems with extremely narrow spaces like Da Vinci SP, urological surgery remains the earliest FDA-approved indication (in 2018) due to overwhelming demand.9 The meticulous pyeloplasty or partial nephrectomy techniques (only removing the tumor, preserving maximum healthy renal parenchyma to maintain filtration function) have become routine procedures at many major urology centers worldwide.33

In the field of gynecology and gynecologic oncology, robotic intervention particularly demonstrates superiority in hysterectomy techniques for large uterus cases, myomectomy preserving the uterus for young women, pelvic organ prolapse repair, and deep infiltrating endometriosis resection.21 Patients diagnosed with endometrial cancer or cervical cancer often face extensive pelvic and para-aortic lymph node dissection surgeries. Robotic intervention allows surgeons to perform more thorough lymphadenectomy (helping to accurately stage the disease), while minimizing blood loss compared to open surgery, opening up good recovery opportunities for even late-stage cancer patients who relapse after concurrent chemoradiotherapy.21

5.2. General Surgery, Gastrointestinal Surgery, and Thoracic Surgery

Applications in thoracic surgery (lobectomy, mediastinal and thymus tumor resection) and gastrointestinal surgery (colorectal, gastric, liver, bile, pancreas resection) are witnessing exponential growth.15 Robotic-assisted thoracic surgery (RATS) is now particularly strongly supported by Force Feedback technology on the Da Vinci 5 generation, partially compensating for the lack of safety sensation when dissecting near large blood vessels close to the heart like the pulmonary artery.25 Colorectal resection (especially low and ultra-low rectal tumor resection) with extremely narrow pelvic space in males is extremely suitable for the multi-jointed, flexible structure of robotic arms, allowing exposure and total mesorectal excision.40 Other common procedures like cholecystectomy or ventral hernia repair are also increasingly being widely deployed.42

However, experts also emphasize that not all patients are ideal candidates for this technology. Patients with severe obesity may face limitations in abdominal space for robotic arms to move without collision; patients with dense scar tissue due to previous complex abdominal surgeries also pose challenges for robotic exploration; or patients with severe underlying medical conditions such as coagulopathy, heart failure, severe pulmonary insufficiency that cannot withstand prolonged abdominal insufflation pressure, still need to be carefully evaluated and considered by doctors before deciding on robotic surgery.43

5.3. Large-Scale Meta-Analysis of Clinical Outcomes

To scientifically quantify the superiority of the Da Vinci system compared to traditional approaches, a massive and unprecedented meta-analysis was published in the prestigious surgical journal Annals of Surgery at the end of 2024. This analysis was conducted by independent scientists from Massachusetts General Hospital in collaboration with Intuitive, providing accurate evidence-based perspectives.44 The dataset covers 230 studies from 22 countries over a 12-year period (including 34 high-quality randomized controlled trials, 74 prospective studies, and 122 large-scale database reviews), summarizing the results of over 1 million surgical procedures in 7 cancer specialties, directly comparing robotic, traditional laparoscopy (Lap/VATS), and open surgery.44

Table 1. Comparison of Clinical Outcomes: Da Vinci Robot (dV-RAS) vs. Traditional Laparoscopy (Laparoscopy/VATS) and Open Surgery in Cancer Tumor Surgery 44

The results from the table above reflect a characteristic trade-off in the application of medical technology: surgeons accept the trade-off of increased operative time (mainly due to sterile preparation, trolley positioning, and docking time) in exchange for maximum safety and structural integrity for the patient. The reduction in severe complications, decreased need for allogeneic blood transfusion, and significantly shortened hospital stays are sharp evidence that robots not only optimize technical manipulation but also directly contribute to the Enhanced Recovery After Surgery (ERAS) model.21

Specifically, in advanced techniques such as Right hemicolectomy, analysis data indicates that although traditional laparoscopy offers a time-saving advantage (faster by 25.73 to 42.45 minutes), the robotic method shows a superior advantage in the higher number of lymph nodes harvested (average difference MD 1.34 for CME technique surgeries). This increase in lymph nodes provides clear oncological benefits, aiding doctors in accurately staging the disease for appropriate adjuvant chemotherapy regimens.40 The conversion rate to open surgery is lower by up to 56% compared to laparoscopy, a telling figure that saves countless patients from the invasive damage of a large midline laparotomy due to difficulties in hemostasis or adhesiolysis faced by laparoscopic surgeons.45

6. Kinetics of the Learning Curve in Robotic Surgery

Overcoming the technical limitations of instruments does not equate to completely eliminating the learning curve for human knowledge. Approaching a completely new operating interface like the Console, where surgeons do not directly touch the patient's body, requires a strong restructuring of spatial perception and hand-eye coordination. Data from surgical studies show that the number of surgeries required for a doctor to reach proficiency varies greatly, directly depending on the specific complexity of each type of surgery.47

For robotic prostatectomy, clinical reports record a very wide range from 10 to 250 surgeries for a doctor to fully master all anatomical situations, while partial nephrectomy (tumor enucleation) requires up to 150 cases to truly master the technique of renal parenchymal hemostatic suturing within the controlled time frame.47 In the field of benign gynecology, studies evaluating operational time stability show that the total operative time for hysterectomy stabilizes at around 95 minutes after the surgeon surpasses the first 50 surgeries. Notably, this time reduction occurs independently and is not influenced by the size of the uterine mass.36

Further evaluation through the Cumulative Sum (CUSUM) model also reveals interesting inflection points. In hysterectomies with super-large size (>1000g), overall procedural proficiency, Console working time, and especially morcellation time to remove tissue from the abdominal cavity often reach optimal points and plateau after the surgeon performs about 20 cases.48

The advent of the Da Vinci Single-Port (SP) system presents an intriguing scientific discovery about the brain's ability for "transferable skills." According to CUSUM analysis, a surgeon who has gone through the learning curve and mastered the Multiport (MP) system after more than 50 surgeries can drastically shorten the learning curve to just 13 cases when transitioning to the new SP system (with a learning rate of -0.009 minutes/case compared to -0.3 minutes/case for MP). This demonstrates that the human motor nervous system can adapt and rapidly reuse spatial knowledge for robotic interfaces if these platforms share a common architectural ecosystem and design philosophy.49 This is also the weapon that creates a huge competitive advantage for Intuitive Surgical in retaining hospital systems from switching to competitors' platforms, as the opportunity cost and medical risk of making doctors "relearn from scratch" are too great.

7. Health Economics and Global Competitive Balance

7.1. Cost Structure of Ownership and Operation

Cost is always the biggest bottleneck, creating an invisible barrier preventing the explosion and popularization of RAS in developing countries and hospitals with tight budgets.41 A comprehensive health economics analysis for the robotic surgery system contains three core variables:

1. Capital expenditure: Requires a massive initial investment, typically around 3 million USD for purchasing the complete Da Vinci hardware system.39
2. Annual maintenance costs: Expensive maintenance contracts to ensure software and hardware operate without errors.
3. Consumables costs: This is the segment that generates continuous revenue for the company. Sophisticated instruments like EndoWrist have integrated memory counters, strictly limiting the number of uses (usually 10 times) to ensure absolute mechanical precision of cables and sterile standards. Once the limit is reached, the instrument automatically locks and must be replaced.41

However, quantifying the "cost" of robotic surgery is a complex multi-layered equation.8 Although the direct cost per surgery of the robotic system is significantly more expensive than traditional laparoscopy, the macro healthcare system benefits invisibly from earlier patient discharge (saving inpatient bed day costs), lower complication rates, reduced blood product use, and especially the decline in massive costs associated with handling readmissions due to leakage or infection complications.40 Maximizing the capacity of the reprocessing cycle with automation technologies, while managing instrument inventory with intelligent systems, can help healthcare facilities significantly reduce this hidden cost burden.50

7.2. The Rise of Rival Platforms: Hugo RAS and Versius

The nearly two-decade-long monopoly of Da Vinci in the healthcare market is being directly challenged by the rising wave of new-generation robotic systems. These competitors aim to democratize robotic surgery by breaking the monopoly cost structure and redefining design architecture to suit more economic conditions.41

• Medtronic Hugo™ RAS (Robotic-Assisted Surgery): Designed through technology transfer from the German Aerospace Center (DLR), Hugo RAS abandons the monolithic cart design characteristic of Da Vinci. Instead, this platform opts for a modular architecture with robotic arms mounted on fully independent mobile pedestals. This structure allows hospitals to optimize space flexibly, especially useful for operating rooms with limited space.42 Hugo's console is an open 3D design, different from Da Vinci's isolated "immersive microscope" design. The open structure allows surgeons to communicate visually and issue commands more easily with the anesthesia and surgical team.42 At AIIMS Delhi (India), the Hugo RAS system has demonstrated safety through over 400 surgeries, including complex techniques such as radical cystectomy and partial nephrectomy, with flexible deployment cost advantages, strongly attracting markets outside the US.42
• CMR Versius: An outstanding technology representative from the UK also applies a flexible modular philosophy with individual robotic arms. However, Versius faces some operational time barriers. A direct clinical study comparing ventral hernia repair results showed that the average operative time for the Versius system group was significantly longer than the Da Vinci system group (103 minutes compared to 72.3 minutes).54

Table 2. Comparison of Depreciation Costs for Robotic-assisted Radical Prostatectomy: Da Vinci vs. Versius 51

Data from the table above highlights a paradoxical reality: Although the consumable material costs (robotic kit) of Versius are significantly cheaper, the prolonged surgery time dramatically increases the depreciation costs of the operating room (OR1 costs) and manpower, pushing the total cost higher than Da Vinci in some specific financial models.51 Besides the two systems mentioned above, platforms from the Asian region such as Toumai, KangDuo (China), or Hinotori (Japan) are also joining the race to reduce costs.41

Despite facing numerous competitive pricing options, Da Vinci still maintains an absolute dominant market share at high-volume surgical centers and in ultra-complex specialized techniques. This exclusivity is protected by the maturity of the software ecosystem, the diversity and mechanical quality of the microsurgical instrument inventory, and the unwavering trust of the medical community, which has been validated over more than 20 years of application.14 An equally important factor is the strong push from the patients themselves. Thanks to Intuitive's successful mass communication strategy, many patients actively seek out hospitals and directly request surgery using the Da Vinci robot. This market pressure forces hospital directors to invest in the most expensive robotic systems if they do not want to lose high-end customers to rival medical facilities.8

8. Overview of Robotic Surgery in Vietnam: Transfer, Costs, and Training Strategy

The Vietnamese healthcare system, despite constantly facing significant barriers in public investment budgets, has shown remarkable agility and rapid adaptation to the world's top surgical trends. The comprehensive picture of robotic surgery application in Vietnam is a powerful testament to the aspiration to modernize the country's medical field and the effort to bring equitable healthcare to the people.3

8.1. Historical Milestones and High-Tech Penetration

The foundation for Vietnamese robotic medicine was laid in 2014 when the National Children's Hospital (Hanoi) pioneered as the first medical facility in the country to deploy the Da Vinci system (Si generation) to perform complex laparoscopic surgeries for pediatric patients.3 However, this elite application on adult patients truly exploded and made a significant impact at the end of 2016. On December 10, 2016, Binh Dan Hospital (Ho Chi Minh City) officially inaugurated the Robotic Surgery Area. Under the direction of Dr. Tran Vinh Hung (Hospital Director), this was the first American-made Da Vinci robotic system licensed by the Ministry of Health for specialized treatment for adults in Vietnam, opening up the hope of accessing high-tech medical care at domestic costs for thousands of patients instead of having to go abroad.6 Following that success, during the 2016-2017 period, major public hospitals such as Cho Ray Hospital in Ho Chi Minh City (under the guidance of Dr. Pham Thanh Viet and leading surgical experts) and Bach Mai Hospital in Hanoi also successively put similar systems into operation.3 K Hospital (Hanoi) also quickly applied this technology to the strategy of radical lymph node dissection in the treatment of gastrointestinal cancer.56

The 2024-2026 period marks a remarkable advancement in updating the latest generation technology configuration, with strong participation from the private healthcare sector:

• FV Hospital (Ho Chi Minh City): To realize the strategic ambition of becoming the leading robotic surgery center in Southeast Asia, FV Hospital (under the leadership of CEO Dr. Jean-Marcel Guillon) decided to invest heavily over 3 million USD to import the complete Da Vinci Xi system – the second most advanced platform in the world today.15 On January 3, 2026, a lobectomy for a malignant tumor (10-13mm) on a 72-year-old female patient was successfully performed by Dr. Dang Dinh Minh Thanh. The tumor was completely removed in just 20 minutes through ultra-small incisions of 8mm on the chest wall, minimizing trauma for the elderly patient.15 By March 12, 2026, this hospital officially launched the FV Da Vinci Robotic Surgery Center, bringing together top experts trained in Japan, South Korea, and Singapore.14 Notably, FV's robotic ecosystem is further enhanced by the CyberKnife S7 robotic radiosurgery system valued at nearly 200 billion VND (invented by Dr. John R Adler), integrating AI with a 6MV linear accelerator robotic arm to treat mobile tumors with an error margin of less than 1 millimeter.62
• Tam Anh General Hospital System: Not lagging in the technology race, the Tam Anh system has recorded a milestone of successfully performing nearly 200 surgeries with the new generation Da Vinci system.63 Besides the Da Vinci Xi system used in cancer and complex disease surgeries, this facility also asserts its technological leadership by operating a series of other specialized robots. Among them is the new generation CUVIS-Joint AI knee replacement robot (making Vietnam the 9th country in the world to own this technology, supporting precise bone cutting to the millimeter) and the AI Modus V Synaptive (Canada) robot system specialized for neurosurgery.58 A classic example of Modus V's performance is the emergency awake craniotomy for a 90-year-old male patient with a large cerebral hemorrhage (50-60ml), excellently performed by Dr. Chu Tan Si, saving the patient without the need for general anesthesia with intubation.3
• Vinmec International General Hospital: Vinmec made its mark by inaugurating the first private Robotic Surgery Center in Vietnam, bringing this high-tech into routine use in general and oncological surgery indications.66

8.2. Economic Barriers and Health Insurance Payment Mechanisms

Despite undeniable clinical benefits, access costs remain a huge gap between high-tech and the majority of patients in Vietnam.

Referring to the publicly disclosed service price list (2019/update) at Binh Dan Hospital – a leading public medical facility, the cost of performing a robotic-assisted laparoscopic surgery for procedures such as bladder tumor resection, nephrectomy, total prostatectomy, bladder reconstruction with intestine, or pelvic organ prolapse treatment is listed at 120,749,000 VND. For gastrectomy, colorectal resection, or esophagectomy, the price is 124,227,000 VND. The most specific and highest are thoracic surgeries such as lung tumor resection and mediastinal tumor resection, costing up to 134,714,000 VND.34 At high-end private facilities like Vinmec or FV, due to the enormous initial investment depreciation costs (over 3 million USD) and the quality of accompanying room services, the final total cost for a surgery will vary greatly depending on the complexity of the treatment regimen.39

Although the above cost is a huge number compared to the average income of domestic workers, it is still many times lower, saving significant foreign currency for the country compared to patients having to buy plane tickets abroad (such as to Singapore or Thailand) for treatment.6 A humanitarian highlight in social welfare policy is that the Health Insurance Fund (BHYT) has begun to apply partial payment frameworks for this high-tech category at public hospitals. For example, for a robotic pyeloplasty at Binh Dan Hospital, the payment value covered by BHYT (according to the guidance in Circular 35/2016/TT-BYT) is up to 41,422,000 VND (on a total bill of 120 million), helping to share a significant financial burden with patients, increasing survival opportunities for poor patients with serious illnesses.34 Current regulations also note that cosmetic reconstructive surgeries are not covered by BHYT, ensuring that funds are focused on essential medical interventions.69

8.3. Human Resource Autonomy Strategy and Technology Localization Ambition

Owning a million-dollar robotic machine is just the body; the human resources (surgeons, anesthesiologists, operating room nurses) are the soul that determines the patient's survival. Deeply aware that paying tuition fees to send doctors to train at international centers is extremely expensive and does not meet the urgent need for personnel, leading hospitals in Vietnam have implemented autonomous training, technology transfer as a nucleus spreading to the national healthcare network.

• Binh Dan Hospital has risen to become a spearhead specialized training center by continuously organizing Continuous Medical Education (CME) courses on robotic surgery. The training course (usually lasting 01 month, with a workload of 160 lessons) applies a rigorous "1-on-1" training mechanism. The content covers everything from practicing on simulators, learning the system's structural principles, abdominal entry techniques, instrument sterilization procedures, to the most important technique of docking the robotic arm to the patient. Heads/deputy heads of departments from major hospitals such as Hanoi Medical University Hospital (Assoc. Prof. Dr. Hoang Long), Ho Chi Minh City Oncology Hospital, Thong Nhat Hospital, and Vinmec Can Tho all send personnel to train at this facility.70
• In the Central region, a historic event took place on March 30, 2026, when Hue Central Hospital made a significant impact by signing a Memorandum of Understanding (MOU) with MicroPort MedBot (China) and Hanoi Foreign Medical to establish the first Vietnam-China Robotic Surgery Training Center in Vietnam. This event not only helps diversify accessible technology platforms (bringing MedBot's Toumai robot into the ecosystem alongside Da Vinci) but also aims to make Thua Thien Hue a "hub" for high-tech medical training in Southeast Asia.55

Besides importing systems, an extremely noteworthy signal about the future of the high-tech supply chain in Vietnam is the move from global industrial corporations. According to the latest environmental impact assessment report, Foxconn (Taiwan) is planning to expand its investment by an additional 58.3 million USD into its subsidiary Fushan Technology in Bac Ninh to produce advanced automation equipment. The focus of this project includes adding more than 100 high-tech items, most notably the production of humanoid and industrial robots, bringing the total factory capacity to 173.4 million products per year with over 130,000 workers.73 Although this component ecosystem currently mainly serves the automation industry, establishing a precise mechanical, automation, and mold technical infrastructure in the domestic market is an essential and huge stepping stone if Vietnam wants to nurture the ambition to independently research, manufacture, and localize a portion of sophisticated medical devices in the next decade, reducing absolute dependence on European and American medical corporations.57

9. Future Outlook: The Revival of Remote Surgery and the Era of Automation

The development trajectory of Da Vinci and satellite mechatronic technologies is not confined behind the doors of local operating rooms. Back in 2001, the iconic "Lindbergh Operation" sowed the first seeds for the dream of intercontinental surgery (Telesurgery).1 However, for more than two decades, the enormous deployment costs of dedicated fiber optic networks and the latency risk of traditional telecommunications have prevented this dream from becoming a routine commercial reality.74

The explosion of new generation 5G telecommunications networks and the preparation to advance to 6G is now breathing new life into this ambition. Most notably, on June 14, 2025, a surgical team from Orlando, Florida (USA) successfully performed a robotic prostatectomy on a patient in Luanda (Angola) – overcoming a massive geographical distance of nearly 11,000 km.74 Notably, this surgery did not use the familiar Da Vinci system but was performed on the Toumai robot system by MedBot (chosen by the Angolan government for its economic advantage). The FDA's approval through the Investigational Device Exemption (IDE) mechanism with stringent fallback mechanisms requirements proves that the legal framework for Telesurgery is being strongly reactivated.74

Along with telecommunications, the deep integration of AI is paving the way for Semi-autonomous tasks in the operating room. Although the prospect of a robot fully performing surgery on a patient still belongs to science fiction due to ethical and legal barriers, in the near future, the next generation Da Vinci system will be able to automatically perform repetitive sutures along long incisions, automatically track target tissues, or automatically adjust suture tension under continuous supervision and approval by the surgeon. This will free up intellectual labor, drastically reduce medical errors due to fatigue at the end of long surgeries.

10. General Conclusion

The Da Vinci surgical robot system is not merely an upgrade of laparoscopic surgery, but it represents the pinnacle of mechatronics, optics, and computer science applications in medicine. By providing superior 3D vision, surpassing the natural limits of human wrist freedom thanks to the EndoWrist platform, and especially the revolutionary Force Feedback system on the Da Vinci 5 generation, this platform has redefined concepts of anatomical limits, mechanical precision, and ultimate safety in surgery.

The medical efficacy of the robotic system has been validated through millions of real clinical cases and objective meta-analyses, demonstrating its ability to significantly reduce blood loss, minimize severe postoperative complications, and dramatically shorten patient hospital stays. Although deep barriers regarding ownership costs, enormous consumable material costs, and the steep learning curve remain as unsolved challenges, the overall economic structure of the hospital (through complication reduction, bed optimization) and the superior quality of life for patients have proven the sustainable profitability of this technology system.

In Vietnam, the process of applying this high-tech is happening at a rapid pace. Not only keeping up with the trends of the most advanced healthcare systems in the region, Vietnamese healthcare is vigorously spreading this technology through healthcare socialization strategies at large-scale private facilities, along with efforts to expand Health Insurance payment coverage in the public sector. The autonomy in building specialized robotic surgery training centers domestically, partnering with diverse international partners, is a strategic move, ensuring high-quality human resources to operate this technology ecosystem independently and sustainably. At the same time, the domestic precision mechanical industry is gradually forming, nurturing further ambitions for the medical supply chain in the next decade.

Moving forward, in the next decade, as the limitless analytical power of Artificial Intelligence perfectly blends with ultra-sensitive tactile technology and wide-bandwidth telecommunications networks, surgical robots will shed the image of a passive mechanical tool. They will evolve to become an intelligent and sophisticated "digital assistant," opening up an era of fully personalized treatment processes, bringing minimally invasive surgery to absolute perfection. The future of surgery is now no longer determined solely by the sharp scalpel in the surgeon's hand, but is firmly shaped by machine learning algorithms and the invisible sensor nodes of a sophisticated mechatronic ecosystem.